May 2017: Members of the Ixchelsis Scientific Advisory Board Present Clinical Results for a Study of IX-01 in Men with PE at American Urological Association Meeting. Boston May 12th -16th 2017

Ixchelsis is pleased to announce that two abstracts relating to the results of the proof of concept trial (PEPIX) of IX-01 in men with lifelong premature ejaculation were accepted for presentation at the American Urology Association Annual Meeting.   The main efficacy and safety results of the trial were presented by the Principal Investigator, Dr Chris McMahon at a podium session on Tuesday May 16th.  The abstract reference is PD69-01 and a link to the abstract is provided here .

The results from the combination of objective and subjective efficacy instruments used in this study  were further analysed and found to be highly correlated.  A summary of these results were presented by Dr Stan Althof at a moderated poster session on Monday May 15th.  We are very pleased to  announce that this was awarded best poster in the Sexual Dysfunction Evaluation II Poster Session. The abstract reference is MP84-07 and a link is provided here .

Ixchelsis Scientific Advisory board AUA Meeting-Boston

Dr Stan Althof also presented a brief overview of the development of IX-01 for PE as the Meeting of the Sexual Medicine Society of North America on Friday May 12th.